Current GROWTH10 verification

Current documented cart record — September 20, 2026 at 1:20 a.m. EDT

Code: GROWTH10 · Growth Guys · Discount observed: 10% · Method: Automated cart observation · Coupon applied.

View GROWTH10 current verification
← Back to resources

GROWTH10 Editorial Desk

Inside Growth Guys batch testing

Reading the COA and endotoxin report for RET26

A useful laboratory record lets a reader follow the evidence from a product listing to the underlying report. This historical Retatrutide 10mg example follows that route through a named batch, separate purity-and-mass and endotoxin entries, and supplied report screenshots carrying the same batch identifier.

Retatrutide 10mgBatch RET26Tasks 225270 and 225272Supplied historical screenshots

Published editorial record ·

The practical value is traceability. A reader can identify which batch a page describes, inspect individual results, check dates, and retain the documents that were available for that batch. The figures below show those steps using supplied historical screenshots for RET26; they are not presented as current offers or a statement about a later batch.

Start with the batch on the product page

The product screenshot identifies Retatrutide 10mg. In this example, its laboratory panel identifies batch RET26 and separates purity-and-mass from endotoxin, with a report link for each. The panel displays 99.82% average purity and 10.69 mg average mass; the separate endotoxin entry has its own link.

The supplied report screenshots provide the next check. Task 225270 names Growth Guys Canada as the client, Retatrutide as the sample, and RET26 as the batch. Task 225272 carries the same client, sample, and batch. Those matching fields connect the documents to the product-panel example; they do not identify an individual delivered vial, which is a separate comparison for a recipient to make.

Historical mobile product-listing screenshot for Retatrutide 10mg.
Figure 1. Supplied historical product-listing view for Retatrutide 10mg. Price and availability are not presented as current offers.
Historical mobile laboratory panel showing Retatrutide 10mg batch RET26.
Figure 2. Supplied RET26 laboratory panel with separate report links, test dates, and upload dates.

Read the individual results before the average

Task 225270 presents multiple results for mass and purity. The report does not assign separate vial identifiers, so the figures below are labeled as result positions rather than individual-vial results.

Result positionReported massReported purity
110.76 mg99.822%
210.86 mg99.810%
310.54 mg99.824%
Historical supplied screenshot of Janoshik task 225270 for Retatrutide batch RET26.
Figure 3. Supplied view of task 225270 with the displayed RET26 mass and purity result positions.

Check that the summary matches the document

Averaging the three reported purity results gives approximately 99.8187%, which rounds to the 99.82% shown on the product panel. The displayed mass values total 32.16 mg; divided by three, they give 10.72 mg, while the panel screenshot shows 10.69 mg. The supplied screenshots do not explain that difference, so this editorial preserves both figures rather than silently changing either source.

This is also where sampling language matters. The screenshots illustrate multi-result testing, but they do not establish how submitted material was selected or a fixed sampling count for every product. The client field names Growth Guys Canada; that wording alone does not establish independent consumer sampling.

Read the endotoxin result exactly as written

The separate endotoxin report is task 225272, with analysis conducted August 24, 2026. Its displayed result is less than 1 EU/vial. The less-than sign is part of the reported finding and is retained here. The product-panel screenshot displays 1 EU/vial without that sign, so the underlying report provides the more precise wording.

Unlike the purity-and-mass report, this document shows one endotoxin result rather than a separate result for each position. The two documents are therefore reported on their own terms, without assuming the same sampling arrangement. Neither document is a blanket certification of clinical safety.

Historical supplied screenshot of Janoshik task 225272 showing the RET26 endotoxin result.
Figure 4. Supplied view of task 225272 for batch RET26; the displayed endotoxin result is <1 EU/vial and the analysis date is August 24, 2026.

Keep the documents that belong to your batch

For a useful saved record, retain the product laboratory panel, both full reports, task numbers, verification details, and batch identifier. A photograph of a received batch label is a separate comparison point. Saving the original report is preferable to keeping only a cropped results table because the surrounding identifiers and dates are what make that table traceable.

Growth Guys’ Lab Results section contains both current and archived reports. The product page is the clearest starting point for the currently listed batch: open its linked reports and match the batch identifiers. Earlier documentation remains available through Lab Results when the listing changes. Saving a copy is useful for personal record-keeping; it does not imply that older reports disappear. Always match an archived report to its own batch rather than assuming it covers the current listing.

RET26 illustrates the value of publishing accessible reports: readers can follow identifiers, examine separate measurements, and even spot a summary that needs clarification. The strongest account of that transparency is the one that shows the documents and reads them accurately.

Read the current documented GROWTH10 record

The current cart observation is separate from this historical batch-testing editorial.

Current GROWTH10 record

Related resources

GROWTH10 Verification Desk
GROWTH10
Shop